Cover Image

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation

Saved in:

Bibliographic Details
Main Authors:	Matthew D. Griffin (Author), Sundararaman Swaminathan (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase
by: Femke Hümmeke-Oppers, et al.
Published: (2019)

Editorial: Insights in renal pharmacology: 2021
by: Norberto Perico, et al.
Published: (2022)

Editorial: Targeting the Chemoattractant System in Inflammation
by: Tadashi Hosoya, et al.
Published: (2021)

Editorial: Leukocyte biology and muscle pathology: Leukocytes as potential targets to control muscle inflammation, mass, and pain
by: Miriam S. N. Hohmann, et al.
Published: (2023)

Editorial: Targeting inflammation to prevent complications in stroke
by: Lourdes M. Varela, et al.
Published: (2023)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
by: Boris V. Chernyak, et al.
Published: (2021)

Editorial: Targeting Monocytes/Macrophages to Treat Atherosclerotic Inflammation
by: Alessandro Corti, et al.
Published: (2020)

Editorial: Inflammation and immune diseases: Molecular targets for pathogenesis and treatment
by: Fan-Rong Wu
Published: (2023)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
by: Alexey V. Sokolov, et al.
Published: (2022)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
by: Ralf Weiskirchen, et al.
Published: (2021)

Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation
by: Anna Salvati, et al.
Published: (2022)

Effect of Inflammation on Molecular Targets and Drug Transporters
by: Sherif Hanafy, et al.
Published: (2012)

Editorial: Biological drugs and biosimilars in autoimmune diseases
by: Anna Wajda, et al.
Published: (2023)

Editorial: Metalloenzymes: Potential Drug Targets
by: Jamshed Iqbal, et al.
Published: (2021)

Editorial for targets and anticancer drug research
Published: (2017)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
by: Yongyi Liang, et al.
Published: (2023)

Editorial: Stem Cells as Targeted Drug Delivery Vehicles
by: Gina D. Kusuma, et al.
Published: (2020)

Building inclusive health innovation systems: lessons from India
by: Dinesh Abrol, et al.

Impact of Viral Inflammation on the Expression of Renal Drug Transporters in Pregnant Rats
by: Navaz Karimian Pour, et al.
Published: (2019)

Editorial of Special Issue "The Biological Fate of Drug Nanocarriers"
by: Wei Wu, et al.
Published: (2021)

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
by: Daniel Heudobler, et al.
Published: (2021)

Editorial: Molecular targets in oncological and hematological disease management: innovations in precision medicine
by: Adrian Bogdan Tigu, et al.
Published: (2024)

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation
by: Debora Collotta, et al.
Published: (2023)

Synthetic Biology Speeds Up Drug Target Discovery
by: Yixuan Xie, et al.
Published: (2020)

Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery
by: Lu Tang, et al.
Published: (2021)

Editorial: Orphan GPCRs as emerging drug targets
by: Ye eFang, et al.
Published: (2015)

Editorial: Innovative pharmacometric approaches to inform drug development and clinical use
by: Maria Garcia-Cremades, et al.
Published: (2023)

Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases
by: Baoming Wu
Published: (2022)

Editorial of special column on Drug targets and drug development for Alzheimer's disease
by: Wen-Xing Ding, et al.
Published: (2022)

Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond
by: Ricardo A. M. Serafim, et al.
Published: (2024)

Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic
by: Giulio Cavalli, et al.
Published: (2020)

Editorial: Adenylyl cyclase isoforms as potential drug targets
by: Tarsis F. Brust, et al.
Published: (2022)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
by: Juraj Mokry, et al.
Published: (2021)

Natural drugs targeting inflammation pathways can be used to treat atherosclerosis
by: Xiayinan Song, et al.
Published: (2022)

Biologics Beyond Boundaries: Innovative Use of Biologics in Dermatology
by: Abhishek De, et al.
Published: (2021)

Editorial: Cancer of gastrointestinal tract: Novel insight into the molecular mechanisms related to inflammation and therapeutic targets
by: Aditi Banerjee, et al.
Published: (2022)

Editorial: Bypassing the Biological Barriers by Means of Biocompatible Drug Delivery Systems
by: Vibhudutta Awasthi, et al.
Published: (2021)

Innovative Design of Targeted Nanoparticles: Polymer-Drug Conjugates for Enhanced Cancer Therapy
by: Varaporn Buraphacheep Junyaprasert, et al.
Published: (2023)

Dermatology quality of life in renal transplant recipients in the West of Ireland
by: Laoise Griffin, et al.
Published: (2024)

Dual-targeting for brain-specific drug delivery: synthesis and biological evaluation
by: Qiming Yue, et al.
Published: (2018)